Latest AbbVie Stories
- Results demonstrated high response rates in adult chronic hepatitis C genotype 4 patients without cirrhosis BOSTON, Nov.
NORTH CHICAGO, Ill., Nov. 5, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Credit Suisse 2014 Healthcare Conference on Thursday, Nov. 13, 2014.
NORTH CHICAGO, Ill., Oct.
DUBLIN, October 20, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
- HS is a painful, chronic inflammatory skin disease that impacts approximately 1 percent of the adult population worldwide with no approved treatment options available,, AMSTERDAM,
-- Polyarticular juvenile idiopathic arthritis (JIA) occurs in approximately 25 percent of all JIA patients NORTH CHICAGO, Ill., Oct.
Data from 25 accepted abstracts include results from: NORTH CHICAGO, Ill., Oct.
- AbbVie presents preliminary data from randomized phase 2 trial of veliparib in non-small cell lung cancer NORTH CHICAGO, Ill., Sept.
Presentations include first Phase 2 results evaluating investigational compound Veliparib in patients with non-small cell lung cancer NORTH CHICAGO, Ill., Sept.
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fg8h7p/global) has announced the addition of the "Global Endometriosis
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.